CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company
DBV Technologies S.A.
Sign in to watch- Ticker
- DBVTF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- operating
- Phone
- 330155427878
- Business address
- 107 AVENUE DE LA REPUBLIQUE, CHATILLON, France
Securities
- DBVT American Depositary Shares Nasdaq
- DBVTF Common stock OTC
- 8-K Event Other events
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- F-6EF Other F-6EF
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 11,875,000 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Other events
Page 10 of 29 · 577 filings